160 related articles for article (PubMed ID: 30557593)
1. Expression of immediate early genes in brain reward circuitries: Differential regulation by psychostimulant and opioid drugs.
Bisagno V; Cadet JL
Neurochem Int; 2019 Mar; 124():10-18. PubMed ID: 30557593
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.
Mannangatti P; Sundaramurthy S; Ramamoorthy S; Jayanthi LD
Psychopharmacology (Berl); 2017 Feb; 234(4):695-705. PubMed ID: 28013351
[TBL] [Abstract][Full Text] [Related]
3. Histone Deacetylases and Immediate Early Genes: Key Players in Psychostimulant-Induced Neuronal Plasticity.
Bisagno V; Cadet JL
Neurotox Res; 2021 Dec; 39(6):2134-2140. PubMed ID: 34581974
[TBL] [Abstract][Full Text] [Related]
4. Opioid and Psychostimulant Plasticity: Targeting Overlap in Nucleus Accumbens Glutamate Signaling.
Hearing M; Graziane N; Dong Y; Thomas MJ
Trends Pharmacol Sci; 2018 Mar; 39(3):276-294. PubMed ID: 29338873
[TBL] [Abstract][Full Text] [Related]
5. Stable immediate early gene expression patterns in medial prefrontal cortex and striatum after long-term cocaine self-administration.
Gao P; Limpens JH; Spijker S; Vanderschuren LJ; Voorn P
Addict Biol; 2017 Mar; 22(2):354-368. PubMed ID: 26598422
[TBL] [Abstract][Full Text] [Related]
6. Opioid and nondopamine reward circuitry and state-dependent mechanisms.
Fujita M; Ide S; Ikeda K
Ann N Y Acad Sci; 2019 Sep; 1451(1):29-41. PubMed ID: 29512887
[TBL] [Abstract][Full Text] [Related]
7. Neuroinflammatory Response in Reward-Associated Psychostimulants and Opioids: A Review.
Karimi-Haghighi S; Chavoshinezhad S; Mozafari R; Noorbakhsh F; Borhani-Haghighi A; Haghparast A
Cell Mol Neurobiol; 2023 Mar; 43(2):649-682. PubMed ID: 35461410
[TBL] [Abstract][Full Text] [Related]
8. Role of pharmacokinetic and pharmacodynamic parameters in neuroadaptations induced by drugs of abuse, with a focus on opioids and psychostimulants.
Marie N; Canestrelli C; Noble F
Neurosci Biobehav Rev; 2019 Nov; 106():217-226. PubMed ID: 30340773
[TBL] [Abstract][Full Text] [Related]
9. Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits.
Yano M; Steiner H
Neuroscience; 2005; 132(3):855-65. PubMed ID: 15837145
[TBL] [Abstract][Full Text] [Related]
10. Chronic methamphetamine treatment reduces the expression of synaptic plasticity genes and changes their DNA methylation status in the mouse brain.
Cheng MC; Hsu SH; Chen CH
Brain Res; 2015 Dec; 1629():126-34. PubMed ID: 26496011
[TBL] [Abstract][Full Text] [Related]
11. Activation of an effector immediate-early gene arc by methamphetamine.
Yamagata K; Suzuki K; Sugiura H; Kawashima N; Okuyama S
Ann N Y Acad Sci; 2000 Sep; 914():22-32. PubMed ID: 11085305
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate-early gene Arc in the juvenile and adult brain.
Banerjee PS; Aston J; Khundakar AA; Zetterström TS
Eur J Neurosci; 2009 Feb; 29(3):465-76. PubMed ID: 19222557
[TBL] [Abstract][Full Text] [Related]
13. Reflections on: "A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function".
Nestler EJ
Brain Res; 2016 Aug; 1645():71-4. PubMed ID: 26740398
[TBL] [Abstract][Full Text] [Related]
14. The role of CART in the reward/reinforcing properties of psychostimulants.
Jaworski JN; Jones DC
Peptides; 2006 Aug; 27(8):1993-2004. PubMed ID: 16766084
[TBL] [Abstract][Full Text] [Related]
15. The Protective Effect of Social Reward on Opioid and Psychostimulant Reward and Relapse: Behavior, Pharmacology, and Brain Regions.
Venniro M; Marino RAM; Chow JJ; Caprioli D; Epstein DH; Ramsey LA; Shaham Y
J Neurosci; 2022 Dec; 42(50):9298-9314. PubMed ID: 36517252
[TBL] [Abstract][Full Text] [Related]
16. Glial and neuroinflammatory targets for treating substance use disorders.
Bachtell RK; Jones JD; Heinzerling KG; Beardsley PM; Comer SD
Drug Alcohol Depend; 2017 Nov; 180():156-170. PubMed ID: 28892721
[TBL] [Abstract][Full Text] [Related]
17. Psychostimulants: Basic and Clinical Pharmacology.
McCreary AC; Müller CP; Filip M
Int Rev Neurobiol; 2015; 120():41-83. PubMed ID: 26070753
[TBL] [Abstract][Full Text] [Related]
18. There and back again: a tale of norepinephrine and drug addiction.
Weinshenker D; Schroeder JP
Neuropsychopharmacology; 2007 Jul; 32(7):1433-51. PubMed ID: 17164822
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
Cunha-Oliveira T; Rego AC; Oliveira CR
Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072
[TBL] [Abstract][Full Text] [Related]
20. Brain mechanisms of drug reward and euphoria.
Wise RA; Bozarth MA
Psychiatr Med; 1985; 3(4):445-60. PubMed ID: 2893431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
